NCT06827236: An ongoing trial by Biontech SE
This trial is ongoing. It must report results 3 years, 1 month from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06827236 |
|---|---|
| Title | A Phase I/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT323 in Combination With BNT327 in Participants With Advanced Breast Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 23, 2025 |
| Completion date | May 31, 2028 |
| Required reporting date | May 31, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |